Az idiopathiás tüdôfibrosis (IPF) korszerû diagnosztikája. 1. rész

Translated title of the contribution: Diagnosis of interstitial lung diseases

Research output: Contribution to journalArticle

Abstract

Recognition and diagnosis of interstitial lung diseases (ILD) is one of the most challenging tasks of respiratory medicine. In the wide range of different ILD-s idiopathic pulmonary fibrosis (IPF) is one of the most common. Improvements in the diagnosis made the recognition of IPF easier. Typical clinical features and usual interstitial pneumonia pattern on high resolution CT are now enough for the confident diagnosis of IPF in the multidisciplinary ILD-team discussions. Bronchoscopic cryobiopsy is a great achievement of histological sampling as this can give appropriate size tissue for histological analysis making surgical intervention rare. As IPF cannot be cured early diagnosis is crucial. Today available treatments can only slow down progression of the disease, so early stages and better clinical condition of the patients are essential for therapeutic success. Follow-up of IPF patients includes complex lung functional measurements in dedicated centers in Hungary. Former studies confirmed forced vital capacity (FVC) decline as an important measure of disease progression and mortality. Available IPF treatments decrease FVC decline and can prevent the mostly deadly acute exacerba-tions of the disease. Additionally palliative treatments including supplementary oxygen and in selected patients lung transplantation can be offered. This is the first of a series of three articles about IPF.

Original languageHungarian
Pages (from-to)215-219
Number of pages5
JournalLege Artis Medicinae
Volume28
Issue number4-5
Publication statusPublished - Jan 1 2018

Fingerprint

Idiopathic Pulmonary Fibrosis
Interstitial Lung Diseases
Vital Capacity
Disease Progression
Pulmonary Medicine
Lung Transplantation
Hungary
Palliative Care
Early Diagnosis
Therapeutics
Oxygen
Lung
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az idiopathiás tüdôfibrosis (IPF) korszerû diagnosztikája. 1. rész. / Müller, V.

In: Lege Artis Medicinae, Vol. 28, No. 4-5, 01.01.2018, p. 215-219.

Research output: Contribution to journalArticle

@article{682dc5cb10f742ee94afd15d9b22dcd7,
title = "Az idiopathi{\'a}s t{\"u}d{\^o}fibrosis (IPF) korszer{\^u} diagnosztik{\'a}ja. 1. r{\'e}sz",
abstract = "Recognition and diagnosis of interstitial lung diseases (ILD) is one of the most challenging tasks of respiratory medicine. In the wide range of different ILD-s idiopathic pulmonary fibrosis (IPF) is one of the most common. Improvements in the diagnosis made the recognition of IPF easier. Typical clinical features and usual interstitial pneumonia pattern on high resolution CT are now enough for the confident diagnosis of IPF in the multidisciplinary ILD-team discussions. Bronchoscopic cryobiopsy is a great achievement of histological sampling as this can give appropriate size tissue for histological analysis making surgical intervention rare. As IPF cannot be cured early diagnosis is crucial. Today available treatments can only slow down progression of the disease, so early stages and better clinical condition of the patients are essential for therapeutic success. Follow-up of IPF patients includes complex lung functional measurements in dedicated centers in Hungary. Former studies confirmed forced vital capacity (FVC) decline as an important measure of disease progression and mortality. Available IPF treatments decrease FVC decline and can prevent the mostly deadly acute exacerba-tions of the disease. Additionally palliative treatments including supplementary oxygen and in selected patients lung transplantation can be offered. This is the first of a series of three articles about IPF.",
keywords = "Diagnostics, ILD, IPF",
author = "V. M{\"u}ller",
year = "2018",
month = "1",
day = "1",
language = "Hungarian",
volume = "28",
pages = "215--219",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "4-5",

}

TY - JOUR

T1 - Az idiopathiás tüdôfibrosis (IPF) korszerû diagnosztikája. 1. rész

AU - Müller, V.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Recognition and diagnosis of interstitial lung diseases (ILD) is one of the most challenging tasks of respiratory medicine. In the wide range of different ILD-s idiopathic pulmonary fibrosis (IPF) is one of the most common. Improvements in the diagnosis made the recognition of IPF easier. Typical clinical features and usual interstitial pneumonia pattern on high resolution CT are now enough for the confident diagnosis of IPF in the multidisciplinary ILD-team discussions. Bronchoscopic cryobiopsy is a great achievement of histological sampling as this can give appropriate size tissue for histological analysis making surgical intervention rare. As IPF cannot be cured early diagnosis is crucial. Today available treatments can only slow down progression of the disease, so early stages and better clinical condition of the patients are essential for therapeutic success. Follow-up of IPF patients includes complex lung functional measurements in dedicated centers in Hungary. Former studies confirmed forced vital capacity (FVC) decline as an important measure of disease progression and mortality. Available IPF treatments decrease FVC decline and can prevent the mostly deadly acute exacerba-tions of the disease. Additionally palliative treatments including supplementary oxygen and in selected patients lung transplantation can be offered. This is the first of a series of three articles about IPF.

AB - Recognition and diagnosis of interstitial lung diseases (ILD) is one of the most challenging tasks of respiratory medicine. In the wide range of different ILD-s idiopathic pulmonary fibrosis (IPF) is one of the most common. Improvements in the diagnosis made the recognition of IPF easier. Typical clinical features and usual interstitial pneumonia pattern on high resolution CT are now enough for the confident diagnosis of IPF in the multidisciplinary ILD-team discussions. Bronchoscopic cryobiopsy is a great achievement of histological sampling as this can give appropriate size tissue for histological analysis making surgical intervention rare. As IPF cannot be cured early diagnosis is crucial. Today available treatments can only slow down progression of the disease, so early stages and better clinical condition of the patients are essential for therapeutic success. Follow-up of IPF patients includes complex lung functional measurements in dedicated centers in Hungary. Former studies confirmed forced vital capacity (FVC) decline as an important measure of disease progression and mortality. Available IPF treatments decrease FVC decline and can prevent the mostly deadly acute exacerba-tions of the disease. Additionally palliative treatments including supplementary oxygen and in selected patients lung transplantation can be offered. This is the first of a series of three articles about IPF.

KW - Diagnostics

KW - ILD

KW - IPF

UR - http://www.scopus.com/inward/record.url?scp=85050402228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050402228&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85050402228

VL - 28

SP - 215

EP - 219

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 4-5

ER -